MedPath

汇禹远和(海南)药业有限公司

Ownership
-
Established
2021-05-24
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Betamethasone Sodium Phosphate Injection

Product Name
倍他米松磷酸钠注射液
Approval Number
国药准字H20254262
Approval Date
May 27, 2025
NMPA

Furosemide Tablets

Product Name
呋塞米片
Approval Number
国药准字H20244636
Approval Date
Aug 5, 2024
NMPA

NikethamideInjection

Product Name
尼可刹米注射液
Approval Number
国药准字H41023043
Approval Date
Mar 14, 2024
NMPA

Tropicamide Phenylephrine Eye Drops

Product Name
复方托吡卡胺滴眼液
Approval Number
国药准字H20234730
Approval Date
Dec 29, 2023
NMPA

Digoxin Injection

Product Name
地高辛注射液
Approval Number
国药准字H33021711
Approval Date
Nov 5, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.